Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients

Lumacaftor/ivacaftor therapy fails to increase insulin secretion in F508del/F508del CF patients

Resource Type

CF Research News

Authors

Amir Moheet, Daniel Beisang, Lin Zhang, Scott D Sagel, Jill M VanDalfsen, Sonya L Heltshe, Carla Frederick, Michelle Mann, Nicholas Antos, Joanne Billings, Steven M Rowe, Antoinette Moran, PROSPECT Investigators of the Cystic Fibrosis Foundation
Therapeutics Development Network

References

J Cyst Fibros. 2020 Sep 8;S1569-1993(20)30862-6. doi: 10.1016/j.jcf.2020.09.001. 

Document

PDF icon CF Research News Article [1]

Link

Scientific Abstract [2]

Keywords

CFRD [3]
insulin secretion [4]
Orkambi [5]

Date

Tuesday, September 8, 2020

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/lumacaftorivacaftor-therapy-fails-increase-insulin-secretion

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-20-00101R1_FINAL_Moran_160221.pdf [2] https://pubmed.ncbi.nlm.nih.gov/32917547/ [3] https://www.ecfs.eu/research-article-keywords/cfrd [4] https://www.ecfs.eu/research-article-keywords/insulin-secretion [5] https://www.ecfs.eu/research-article-keywords/orkambi [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines